PMID- 19682579 OWN - NLM STAT- MEDLINE DCOM- 20100204 LR - 20131121 IS - 1878-5492 (Electronic) IS - 0966-3274 (Linking) VI - 22 IP - 1-2 DP - 2009 Dec TI - The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. PG - 44-54 LID - 10.1016/j.trim.2009.08.001 [doi] AB - Kidney ischemia-reperfusion injury (IRI) is an important contributor to delayed graft function (DGF) and poor outcome of allografts. Small clinical studies suggest a beneficial role for human anti-thymocyte globulin (ATG) in DGF. We investigated the short-term effect of mouse anti-thymocyte globulin (mATG) on kidney warm IRI in mice. We administered either mATG, rabbit immunoglobulin (RIgG), or saline with different dosing schedules in three different IRI models: 30 min bilateral, 60 min bilateral, and 45min unilateral IRI. mATG effectively depleted circulating T cells but had less effect on kidney-infiltrating T cells. There was no difference in serum creatinine levels between groups in each study. Scoring of renal tubular damage and regenerating tubules revealed no difference between groups. The percentage of CD3(+)CD4(-)CD8(-) double-negative (DN) T cells, which were reported to contribute to the pathogenesis of lupus nephritis, increased and the percentages of regulatory T cells and NK cells decreased in the post-ischemic kidneys of mATG treated mice. mATG did not alter the expression of pro-inflammatory cytokines such as IFN-gamma or anti-inflammatory cytokines such as IL-10 in post-ischemic kidneys. mATG treatment, whether initiated before ischemia or immediately after reperfusion, had minimal effects on renal injury following warm IRI in mice. FAU - Jang, Hye Ryoun AU - Jang HR AD - Nephrology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. shinehr@gmail.com FAU - Gandolfo, Maria Teresa AU - Gandolfo MT FAU - Ko, Gang Jee AU - Ko GJ FAU - Racusen, Lorraine AU - Racusen L FAU - Rabb, Hamid AU - Rabb H LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090812 PL - Netherlands TA - Transpl Immunol JT - Transplant immunology JID - 9309923 RN - 0 (Antilymphocyte Serum) RN - 0 (Chemokines) RN - 0 (Cytokines) RN - 0 (Immunoglobulin G) RN - AYI8EX34EU (Creatinine) SB - IM MH - Animals MH - Antilymphocyte Serum/*therapeutic use MH - Blood Cell Count MH - Chemokines/metabolism MH - Creatinine/blood MH - Cytokines/metabolism MH - Immunoglobulin G/therapeutic use MH - Kidney/blood supply/metabolism/*pathology/physiopathology MH - Kidney Cortex/pathology MH - Kidney Medulla/pathology MH - Kidney Tubules/pathology MH - Lymphocyte Depletion MH - Lymphocyte Subsets/cytology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Rabbits MH - Reperfusion Injury/immunology/metabolism/pathology/physiopathology/*therapy MH - Spleen/pathology MH - Survival Rate MH - T-Lymphocytes/cytology/immunology EDAT- 2009/08/18 09:00 MHDA- 2010/02/05 06:00 CRDT- 2009/08/18 09:00 PHST- 2009/05/11 00:00 [received] PHST- 2009/07/23 00:00 [revised] PHST- 2009/08/04 00:00 [accepted] PHST- 2009/08/18 09:00 [entrez] PHST- 2009/08/18 09:00 [pubmed] PHST- 2010/02/05 06:00 [medline] AID - S0966-3274(09)00082-3 [pii] AID - 10.1016/j.trim.2009.08.001 [doi] PST - ppublish SO - Transpl Immunol. 2009 Dec;22(1-2):44-54. doi: 10.1016/j.trim.2009.08.001. Epub 2009 Aug 12.